MEDAREX, INC. RIGHTS EXCHANGE AGREEMENT JUNE 10, 1998 TABLE OF CONTENTSRights Exchange Agreement • June 19th, 1998 • BCC Acquisition I LLC • Biological products, (no disgnostic substances) • California
RIGHTS EXCHANGE AGREEMENTRights Exchange Agreement • April 30th, 2020 • PTC Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS RIGHTS EXCHANGE AGREEMENT (this “Agreement”) is made and entered into as of April 29, 2020 (the “Effective Date”), by and between PTC THERAPEUTICS, INC., a Delaware corporation (the “Company”), the Persons listed on Schedule 1 hereto (each, a “Rightholder” and collectively the “Rightholders”), and, for purposes of Sections 4.1, 6.9 and 6.13 only, Shareholder Representative Services LLC (“SRS”). Each of the Company and the Rightholders may be referred to herein, collectively, as the “Parties” and, individually, as a “Party.”
INTRODUCTIONRights Exchange Agreement • August 14th, 1997 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
INTRODUCTIONRights Exchange Agreement • July 30th, 1999 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
AGREEMENTRights Exchange Agreement • June 15th, 1998 • Medarex Inc • Biological products, (no disgnostic substances) • California
